TRADITIONAL Chinese medicine retailer Eu Yan Sang will request a suspension of trading in its shares starting Sept 28 and delist on Oct 7, it said in a Singapore Exchange (SGX) filing on Tuesday.
The delisting spells an end to the group's 16 years on the SGX main board.
It comes after a consortium led by a UOB-backed fund, a Temasek Holdings unit and Eu Yan Sang International's group chief executive officer Richard Eu made a privatisation bid for the company, offering S$0.60 cash for each share that it does not own.
The final closing date for the offer was Sept 27. Eu Yan Sang shares closed a cent higher at S$0.60 on Tuesday.